These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35316579)

  • 21. Dose-proportional pharmacokinetics of a methylphenidate extended-release capsule.
    Rochdi M; González MA; Dirksen SJ
    Int J Clin Pharmacol Ther; 2004 May; 42(5):285-92. PubMed ID: 15176652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse Events During Dosing of Delayed-release/Extended-release Methylphenidate: Learnings From the Open-label Phase of a Registration Trial and a Real-world Postmarketing Surveillance Program.
    Katzman MA; Otcheretko V; Po MD; Uchida CL; Incledon B
    Clin Ther; 2023 Dec; 45(12):1212-1221. PubMed ID: 37770309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative Characterization of the Smoothness of Extended-release Methylphenidate Pharmacokinetic Profiles.
    Po MD; Gomeni R; Incledon B
    Innov Clin Neurosci; 2022; 19(7-9):32-37. PubMed ID: 36204174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of coadministration of guanfacine extended release and methylphenidate extended release.
    Roesch B; Corcoran M; Haffey M; Stevenson A; Wang P; Purkayastha J; Martin P; Ermer J
    Drugs R D; 2013 Mar; 13(1):53-61. PubMed ID: 23519656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative Bioavailability of Methylphenidate Extended-release Chewable Tablets Chewed Versus Swallowed Whole.
    Abbas R; Childress AC; Nagraj P; Rolke R; Berry SA; Palumbo DR
    Clin Ther; 2018 May; 40(5):733-740. PubMed ID: 29703430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR
    Adjei AL; Chaudhary I; Kollins SH; Padilla A
    Paediatr Drugs; 2020 Oct; 22(5):561-570. PubMed ID: 32776159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorder.
    Wigal SB; Gupta S; Heverin E; Starr HL
    J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):255-63. PubMed ID: 21663428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylphenidate bioavailability from two extended-release formulations.
    González MA; Pentikis HS; Anderl N; Benedict MF; DeCory HH; Dirksen SJ; Hatch SJ
    Int J Clin Pharmacol Ther; 2002 Apr; 40(4):175-84. PubMed ID: 11996212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fed and Fasted Administration of a Novel Extended-Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD.
    Weisler RH; Stark JG; Sikes C
    Clin Pharmacol Drug Dev; 2018 Feb; 7(2):160-167. PubMed ID: 28544344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized Controlled Crossover Trials of the Pharmacokinetics of PRC-063, a Novel Multilayer Extended-Release Formulation of Methylphenidate, in Healthy Adults.
    Katzman MA; Mattingly G; Klassen LJ; Cataldo MJ; Donnelly GAE
    J Clin Psychopharmacol; 2020; 40(6):579-587. PubMed ID: 33009228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Post-Hoc Analysis of Emotional Lability With Delayed-Release/Extended-Release Methylphenidate in Children Aged 6 to 12 Years of Age Participating in Two Phase 3 Clinical Trials.
    Arnold VK; López FA; Childress AC; Po MD; Uchida CL; Cuthbertson L; Sallee FR; Incledon B
    J Atten Disord; 2024 Jun; 28(8):1186-1197. PubMed ID: 38600754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of food on early drug exposure from extended-release stimulants: results from the Concerta, Adderall XR Food Evaluation (CAFE) Study.
    Auiler JF; Liu K; Lynch JM; Gelotte CK
    Curr Med Res Opin; 2002; 18(5):311-6. PubMed ID: 12240794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose Proportionality and Steady-State Pharmacokinetics of Serdexmethylphenidate/Dexmethylphenidate, a Novel Prodrug Combination to Treat Attention-Deficit/Hyperactivity Disorder.
    Braeckman R; Guenther S; Mickle TC; Barrett AC; Smith A; Oh C
    J Child Adolesc Psychopharmacol; 2022 Jun; 32(5):288-295. PubMed ID: 35666231
    [No Abstract]   [Full Text] [Related]  

  • 34. Methylphenidate blood levels and therapeutic response in children with attention-deficit hyperactivity disorder: I. Effects of different dosing regimens.
    Teicher MH; Polcari A; Foley M; Valente E; McGreenery CE; Chang WW; McKay G; Midha KK
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):416-31. PubMed ID: 16958567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Quantitative Comparison Approach for Methylphenidate Drug Regimens in Attention-Deficit/Hyperactivity Disorder Treatment.
    Soufsaf S; Robaey P; Bonnefois G; Nekka F; Li J
    J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):220-234. PubMed ID: 30714820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetics of methylphenidate hydrochloride extended-release multiple-layer beads in pediatric subjects with attention deficit hyperactivity disorder.
    Teuscher NS; Adjei A; Findling RL; Greenhill LL; Kupper RJ; Wigal S
    Drug Des Devel Ther; 2015; 9():2767-75. PubMed ID: 26060393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of Physiologically Based Absorption Modeling to Characterize the Pharmacokinetic Profiles of Oral Extended Release Methylphenidate Products in Adults.
    Yang X; Duan J; Fisher J
    PLoS One; 2016; 11(10):e0164641. PubMed ID: 27723791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of food on the pharmacokinetics of methylphenidate.
    Midha KK; McKay G; Rawson MJ; Korchinski ED; Hubbard JW
    Pharm Res; 2001 Aug; 18(8):1185-9. PubMed ID: 11587491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations.
    Childress AC; Komolova M; Sallee FR
    Expert Opin Drug Metab Toxicol; 2019 Nov; 15(11):937-974. PubMed ID: 31581854
    [No Abstract]   [Full Text] [Related]  

  • 40. Methylphenidate bioavailability in adults when an extended-release multiparticulate formulation is administered sprinkled on food or as an intact capsule.
    Pentikis HS; Simmons RD; Benedict MF; Hatch SJ
    J Am Acad Child Adolesc Psychiatry; 2002 Apr; 41(4):443-9. PubMed ID: 11931601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.